NHC vs PACS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 02, 2026

NHC

62.2
AI Score
VS
PACS Wins

PACS

62.3
AI Score

Investment Advisor Scores

NHC

62score
Recommendation
BUY

PACS

62score
Recommendation
BUY

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric NHC PACS Winner
Revenue 789.85M 2.85B PACS
Net Income 76.18M 157.06M PACS
Net Margin 9.6% 5.5% NHC
Operating Income 81.19M 229.37M PACS
ROE 6.8% 14.1% PACS
ROA 5.0% 2.8% NHC
Total Assets 1.54B 5.66B PACS
Cash 39.21M 164.45M PACS
Current Ratio 1.86 0.91 NHC

Relative Price Performance (Last 90 Days)

NHC 1M: +4.7% · 3M: +4.7% PACS 1M: -0.6% · 3M: -4.8%

Current Technical Phase

NHC

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.7% over 20 days), RSI 55

RSI (14): 55.1 · Price: $227.66

PACS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 51

RSI (14): 50.9 · Price: $42.85

Fundamentals Snapshot

Metric NHC PACS
Market Cap — —
Forward P/E 9.9 15.8
Trailing P/E 25.1 24.3
Revenue (TTM) — —
Revenue Growth 0.1% 0.1%
Gross Margin 0.4% 0.2%
Operating Margin 0.1% 0.1%
EPS 8.89 1.69
Dividend Yield 0.01% —

Frequently Asked Questions

Based on our detailed analysis, PACS is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.